Price target upside
Cardiol Therapeutics Inc. - Class A Common Shares Price Target Upside or Downside
CRDL price target upside based on the current price and analyst average.
Direct answer
Cardiol Therapeutics Inc. - Class A Common Shares's analyst target implies +423.3%.
The average target is $7.43 compared with a recorded current price of $1.42.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 9, 2026.
Get free Cardiol Therapeutics Inc. - Class A Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.42
- Average price target
- $7.43
- High price target
- $9.11
- Low price target
- $4.92
- Target upside
- +423.3%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 9, 2026
- Valid through
- August 16, 2026